Search clinical trials for: Mologic Biomarker Panel

Total 4437 results

Qure Healthcare, LLC
SomaLogic, Inc.

Completed

Clinical Utility Trial for the SomaLogic CVD-T2D Test

Cardiovascular Diseases | Type 2 Diabetes

United States
University Hospital, Gentofte, Copenhagen

Completed

Single Dose of 9-cis-retinoic Acid in Hepatic Patients

Hepatic Insufficiency

Denmark
Beni-Suef University

Completed

CRP Versus PCT as Bio-markers for Sepsis and in Guiding Antibiotics in Critically Ill Patients (PCTCRP)

Sepsis | Morality

Egypt
Michigan Institution of Women's Health PC
Coloplast A/S

Active, not recruiting

Axis(TM) Solvent-dehydrate Dermal Allograft in the Treatment of Pelvic Organ Prolapse.

Pelvic Organ Prolapse

United States
University Hospital Heidelberg

Recruiting

Plasma Extracellular Vesicles in Meningioma Patients (MOLI)

Meningioma

Germany
VA Office of Research and Development

Recruiting

Neurophysiologic Biomarkers for Cognitive Rehabilitation

Schizophrenia Spectrum Disorders

United States
Medical University of Warsaw

Recruiting

Evaluation of Novel Biomarkers in Early Recognition of Acute Kidney Injury After Orthopedic Operations.

Hip Fractures | Acute Kidney Injury

Poland
Aventyn, Inc.
Arizona State University; Intel Corporation; TwinEpidemic; Heart Health Organization...

Recruiting

Care Coordination to Assess Improvement in Outcomes in Hospital Readmissions (COMPASSION)

Heart Failure | ADHF | Acute MI

United States
Neuromed IRCCS

Recruiting

Ccf mtDNA as a Neurodegenerative Biomarker

Neurodegenerative Diseases

Italy
Assistance Publique - Hôpitaux de Paris

Completed

Quantify the Benefits of Biomarkers in Routine Patient Care in Kidney Transplant Recipients (EUTRAIN IMPACT)

Renal Transplantation

Spain, France, Germany, Switzerland
University of Michigan
National Institute on Aging (NIA)

Enrolling by invitation

STIM+: PET Biomarker Education & Disclosure (STIM+)

Mild Cognitive Impairment | Dementia; Alzheimer's Type (Etiology)

United States
Abramson Cancer Center at Penn Medicine
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Pilot Study of an NTproBNP Guided Strategy of Cardioprotection (NTproBNP-Guide)

Heart Failure | Lymphoma | Breast Cancer | Cardiomyopathies | Cardiotoxicity | Toxicity Due to Chemotherapy

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Active, not recruiting

Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia

Leukemia | Acute Lymphoblastic Leukemia | Acute Promyelocytic Leukemia

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Untreated Adult Acute Lymphoblastic Leukemia | Untreated Childhood Acute Lymphoblastic Leukemia

United States, Canada, Australia, New Zealand, Puerto Rico, Switzerland
GAP Innovations, PBC

Completed

A Biomarker Database to Investigate Blood-Based and Digital Biomarkers in Participants Screened for Alzheimer's Disease (Bio-Hermes)

Alzheimer Disease | Mild Cognitive Impairment | Alzheimer Disease, Early Onset | Memory Disorders | Memory Impairment | Memory Loss

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

DNA Analysis of Tumor Tissue Samples From Young Patients With Acute Lymphoblastic Leukemia

Childhood Acute Lymphoblastic Leukemia in Remission | Recurrent Childhood Acute Lymphoblastic Leukemia

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer

Lung Cancer

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202

Lung Cancer

United States
KU Leuven

Completed

Development and Validation of a Serum Biomarker for the Diagnostic Work-up of Asthma

Asthma | Biomarkers
Hannover Medical School
Institut National de la Santé Et de la Recherche Médicale, France; F-CRIN

Completed

Soluble Neprilysin, NT-proBNP, and Growth-Differentiation-Factor-15 as Biomarkers for Heart Failure in Dialysis Patients (SONGBIRD)

Heart Failure | End Stage Renal Disease

France, Germany
Children's Oncology Group
National Cancer Institute (NCI)

Withdrawn

Studying Biomarkers in Samples From Younger Patients With Kidney Cancer

Clear Cell Renal Cell Carcinoma | Rhabdoid Tumor of the Kidney | Congenital Mesoblastic Nephroma | Childhood Kidney Neoplasm

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Withdrawn

Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers

Breast Carcinoma | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier

United States
RWTH Aachen University

Unknown

Investigation of the Cerebrospinal Fluid and Further Tissue Samples for Biomarker Indicating Spinal Ischemia and Organ Failure in Patients With Thoracoabdominal Aortic Aneurysm (TAAA)

Thoracoabdominal Aortic Aneurysm

Germany
The Cleveland Clinic

Completed

Tissue Doppler Assessment of Right Ventricular Performance in Acute Heeart Failure (TARVA)

Cardiovascular Diseases

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Samples From Younger Patients With Wilms Tumor

Wilms Tumor and Other Childhood Kidney Tumors

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia

Childhood Acute Monoblastic Leukemia (M5a) | Childhood Acute Monocytic Leukemia (M5b) | Childhood Acute Myeloblastic Leukemia Without Maturation (M1) | Childhood Acute Myelomonocytic Leukemia (M4) | Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma

Childhood Rhabdomyosarcoma | Alveolar Childhood Rhabdomyosarcoma | Embryonal Childhood Rhabdomyosarcoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Patients With Advanced Rhabdomyosarcoma

Recurrent Childhood Rhabdomyosarcoma | Recurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Previously Treated Childhood Rhabdomyosarcoma | Adult Rhabdomyosarcoma | Childhood Alveolar Rhabdomyosarcoma | Childhood Embryonal Rhabdomyosarcoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia

Recurrent Childhood Acute Lymphoblastic Leukemia | B-cell Childhood Acute Lymphoblastic Leukemia | Untreated Childhood Acute Lymphoblastic Leukemia

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying Genes in Samples From Younger Patients With Acute Megakaryoblastic Leukemia

Childhood Acute Megakaryocytic Leukemia (M7) | Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Study of Specimens From Young Patients With Neuroblastoma

Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying DNA in Blood and Bone Marrow Samples From Younger Patients With Acute Myeloid Leukemia

Adult Acute Myeloid Leukemia in Remission | Childhood Acute Myeloid Leukemia in Remission

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic Leukemia

Childhood Acute Lymphoblastic Leukemia in Remission | Recurrent Childhood Acute Lymphoblastic Leukemia | B-cell Childhood Acute Lymphoblastic Leukemia

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia

Chronic Myelomonocytic Leukemia | Fanconi Anemia | Childhood Acute Erythroleukemia (M6) | Childhood Acute Megakaryocytic Leukemia (M7) | Childhood Acute Monoblastic Leukemia (M5a) | Childhood Acute Monocytic Leukemia (M5b) | Childhood Acute Myeloblastic Leukemia With Maturation (M2) | Childhood Acute... and other conditions

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Genetic Biomarkers in Tissue Samples From Patients With Osteosarcoma

Osteosarcoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying Genes Associated With Non-Hodgkin Lymphoma in Young Patients

Childhood Burkitt Lymphoma | Childhood Lymphoblastic Lymphoma

United States
M.D. Anderson Cancer Center
Alere San Diego

Unknown

Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT)

Unspecified Adult Solid Tumor, Protocol Specific | Cardiac Toxicity

United States
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Predictive Factors for Survival in Aggressive Meningiomas (23Men)

Meningioma | Anaplastic Meningioma | Meningioma Atypical

Italy
Bayer

Completed

A Study Called NATION-OS to Learn About the Link Between N-terminal proBNP (NT-proBNP) Levels and Medical Problems Due to Heart Failure (HF) in German Patients With HF (NATION-OS)

Heart Failure (HF)

Germany
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Secondary Acute Myeloid Leukemia | Childhood Acute Myeloid Leukemia in Remission | Childhood Acute Lymphoblastic Leukemia in Remission | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 and other conditions

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Withdrawn

Study of Proteins in Tumor Samples From Patients With Non-Small Cell Lung Cancer

Lung Cancer

United States
ORIOL BESTARD

Completed

Prospective, Randomized Study for Predicting Human Cytomegalovirus (hCMV) Infection Based on Baseline hCMV Specific T-cell Response in Kidney Transplant (RESPECT)

Kidney Transplantation | CMV Infection

Spain, Belgium
Children's Oncology Group
National Cancer Institute (NCI)

Withdrawn

Biomarker Study in Samples From Patients With Malignant Rhabdoid Tumor of the Kidney or Atypical Teratoid Rhabdoid Tumor

Childhood Atypical Teratoid/Rhabdoid Tumor | Rhabdoid Tumor of the Kidney

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Prognostic Biomarkers in Patients With Endometrial Cancer

Recurrent Uterine Corpus Carcinoma | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage IV Uterine Corpus Cancer | Endometrial Adenocarcinoma

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Study of Tumor Samples From Patients With Lung Cancer

Lung Cancer

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Study of Blood Samples From Patients With Osteosarcoma

Recurrent Osteosarcoma | Metastatic Osteosarcoma | Localized Osteosarcoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Gene Expression Profiles to Categorize Wilms Tumors

Recurrent Wilms Tumor and Other Childhood Kidney Tumors | Stage III Wilms Tumor | Stage IV Wilms Tumor | Stage V Wilms Tumor | Stage I Wilms Tumor | Stage II Wilms Tumor

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Lestaurtinib With or Without Chemotherapy Agents in Samples From Young Patients With Leukemia

Childhood Acute Lymphoblastic Leukemia | Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying Chromosomes in Samples From Younger Patients With Neuroblastoma

Neuroblastoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying Biomarkers in Urine Samples From Younger Patients With Wilms Tumor

Recurrent Wilms Tumor and Other Childhood Kidney Tumors | Stage III Wilms Tumor

United States

Search clinical trials for: Mologic Biomarker Panel

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations